Microparticles in physiological and in pathological conditions

Cell Biochemistry and Function

Volumn 28, Issue 7, 2010, Pages 539-548

  Roos, Maria Augusta ^a   Gennero, Luisa ^b   Denysenko, Tetyana ^a   Reguzzi, Stefano ^a   Cavallo, Giovanni ^c   Pescarmona, Gian Piero ^b   Ponzetto, Antonio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Biology and Biochemistry ^*  (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Endothelial derived MPs (EDMPs); Exosomes; Extracellular matrix (ECM); Microparticles (MPs); Platelet derived MPs (PDMPs); Syncytiotrophoblast derived MPs (STBMPs); Tissue Factor (TF)

Indexed keywords

ACUTE GRAFT REJECTION; ANGIOGENESIS; BRAIN ISCHEMIA; CANCER GROWTH; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; DERMATOMYOSITIS; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; HEMOPHILIA; HUMAN; LIFESPAN; MALARIA; MEMBRANE MICROPARTICLE; NONHUMAN; PLATELET MICROPARTICLE; POLYMYOSITIS; PREECLAMPSIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RHEUMATOID ARTHRITIS; STEM CELL TRANSPLANTATION; VACCINATION;

ANIMALS; BIOLOGICAL MARKERS; BIOLOGICAL THERAPY; CELL-DERIVED MICROPARTICLES; CHRONIC DISEASE; DRUG DELIVERY SYSTEMS; EUKARYOTIC CELLS; HUMANS;

EID: 78650439498     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1695     Document Type: Review

References (62)

1. Toth B, Lok CA, Böing A, et al. Microparticles and exosomes: impact on normal and complicated pregnancy. Am J Reprod Immuno 2007; 58(5): 389-402.
2. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21(3): 157-171.
3. Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS. Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 2006; 39(8): 683-690.
4. Tesse A, Martínez MC, Meziani F, Hugel B, Panaro MA, Mitolo V, Freyssinet JM, Andriantsitohaina R. Origin and biological significance of shed-membrane microparticles. Endocr Metab Immune Disord Drug Targets 2006; 6(3): 287-294.
5. Redman CW, Sargent IL. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J Reprod Immunol 2007; 76(1-2): 61-67.
6. Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles and blood-vessel damage. I. Structure, detection and origin. Ned Tijdschr Geneeskd 2004; 148(28): 1376-1380.
7. Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and thrombosis. Scand J Immunol 2007; 66(2-3): 159-165.
8. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006; 20(1): 1-26.
9. Enjeti AK, Lincz LF, Seldon M. Detection and measurement of microparticles: an evolving research tool for vascular biology. Semin Thromb Hemost 2007; 33(8): 771-779.
10. Azevedo LC, Pedro MA, Laurindo FR. Circulating microparticles as therapeutic targets in cardiovascular diseases. Recent Patents Cardiovasc Drug Discov 2007; 2(1): 41-51. Review.
11. Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004; 34(6): 392-401.
12. Freyssinet JM. Cellular microparticles: what are they bad or good for? J Thromb Haemost 2003; 1(7): 1655-1662.
13. Benameur T, Andriantsitohaina R, Martínez MC. Therapeutic potential of plasma membrane-derived microparticles. Pharmacol Rep 2009; 61(1): 49-57. Review.
14. Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol 2007; 137(1): 36-48.
15. Morel O, Toti F, Freyssinet JM. Markers of thrombotic disease: procoagulant microparticles. Ann Pharm Fr 2007; 65(2): 75-84.
16. Meerarani P, Moreno PR, Cimmino G, Badimon JJ. Atherothrombosis: role of tissue factor; link between diabetes, obesity and inflammation. Indian J Exp Biol 2007; 45(1): 103-110.
17. Morel O, Toti F, Hugel B, Freyssinet JM. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 2004; 11(3): 156-164.
18. Morel O, Toti F, Hugel B, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006; 26(12): 2594-2604.
19. Ghosh K, Shetty S. Blood coagulation in falciparum malaria - review. Parasitol Res 2008; 102(4): 571-576.
20. Couper KN, Barnes T, Hafalla JC, et al. Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog 2010; 6(1): e1000744.
21. Ghosh A, Li W, Febbraio M, et al. Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice. J Clin Invest 2008; 118(5): 1934-1943.
22. Wazna E. Platelet-mediated regulation of immunity. Postepy Hig Med Dosw (Online) 2006; 60: 265-277.
23. Nomura S. Platelet activation marker. Rinsho Byori 2003; 51(11): 1096-1101.
24. Jüngel A, Distler O, Schulze-Horsel U, et al. Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1. Arthritis Rheum 2007; 56(11): 3564-3574.
25. Morel O, Hugel B, Jesel L, et al. Procoagulant membranous microparticles and atherothrombotic complications in diabetics. Arch Mal Coeur Vaiss 2004; 97(10): 1006-1012.
26. Nomura S. Dynamic role of microparticles in type 2 diabetes mellitus. Curr Diabetes Rev 2009; 5(4): 245-251. Review.
27. Boulanger CM. Microparticles, vascular function and hypertension. Curr Opin Nephrol Hypertens 2010; 19(2): 177-180.
28. Pirro M, Schillaci G, Bagaglia F, et al. Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis 2008; 197(2): 757-767.
29. Lai RC, Arslan F, Tan SS, et al. Derivation and characterization of human fetal MSCs: An alternative cell source for large-scale production of cardioprotective microparticles. J Mol Cell Cardiol 2010; 48(6): 1215-1224.
30. Goligorsky MS. Clinical assessment of endothelial dysfunction: combine and rule. Curr Opin Nephrol Hypertens 2006; 15(6): 617-624.
31. Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004; 9: 1118-1135.
32. Abid Hussein MN, Böing AN, Sturk A, Hau CM, Nieuwland R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost 2007; 98(5): 1096-1107.
33. Bakouboula B, Morel O, Faure A, et al. Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 2008; 177(5): 536-543.
34. Amabile N, Heiss C, Real WM, et al. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 2008; 177(11): 1268-1275.
35. Baird AE, Wright VL. Vascular biology: cellular and molecular profiling. Semin Neurol 2006; 26(1): 65-74.
36. Lukasik M, Rozalski M, Luzak B, Michalak S, Kozubski W, Watala C. Platelet activation and reactivity in the convalescent phase of ischaemic stroke. Thromb Haemost 2010; 103(3): 644-650.
37. Treadwell SD, Thanvi B, Robinson TG. Stroke in pregnancy and the puerperium. Postgrad Med J 2008; 84(991): 238-245.
38. Mas JL, Lamy C. Stroke in pregnancy and the puerperium. J Neurol 1998; 245(6-7): 305-313.
39. Rovere-Querini P, Castiglioni MT, Sabbadini MG, Manfredi AA. Signals of cell death and tissue turnover during physiological pregnancy, pre-eclampsia, and autoimmunity. Autoimmunity 2007; 40(4): 290-294.
40. Lok CA, Jebbink J, Nieuwland R, et al. Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am J Reprod Immunol 2009; 61(5): 346-359.
41. Messerli M, May K, Hansson SR, et al. Feto-maternal interactions in pregnancies: placental microparticles activate peripheral blood monocytes. Placenta 2010; 31(2): 106-112.
42. Barry OP, Kazanietz MG, Praticò D, FitzGerald GA. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem 1999; 274(11): 7545-7556.
43. Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327(5965): 580-583.
44. Baka Z, Senolt L, Vencovsky J, et al. Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis. Immunol Lett 2010; 128(2): 124-130.
45. Varon D, Shai E. Role of platelet-derived microparticles in angiogenesis and tumor progression. Discov Med 2009; 8(43): 237-241.
46. Chen BA, Zhong YJ, Huang CY, et al. Effects of platelet-derived membrane microparticles on angiogenesis in chick chorioallantoic membranes. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007; 15(5): 1070-1073.
47. Zwicker JI, Furie BC, Furie B. Cancer-associated thrombosis. Crit Rev Oncol Hematol 2007; 62(2): 126-136.
48. Furie B, Furie BC. Cancer-associated thrombosis. Blood Cells Mol Dis 2006; 36(2): 177-181.
49. Sierko E, Wojtukiewicz MZ. Inhibition of platelet function: does it offer a chance of better cancer progression control? Semin Thromb Hemost 2007; 33(7): 712-721.
50. Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol 2009; 27(29): 4834-4838. Review.
51. Tilley RE, Holscher T, Belani R, Nieva J, Mackman N. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res 2008; 122(5): 604-609.
52. Cauwenberghs S, van Pampus E, Curvers J, Akkerman JW, Heemskerk JW. Hemostatic and signaling functions of transfused platelets. Transfus Med Rev 2007; 21(4): 287-294.
53. Morel O, Ohlmann P, Epailly E, et al. Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection. J Heart Lung Transplant 2008; 27(1): 38-45.
54. Nomura S, Ishii K, Inami N, et al. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation. Transpl Immunol 2007; 18(2): 115-121.
55. Doeuvre L, Plawinski L, Toti F, Anglés-Cano E. Cell-derived microparticles: a new challenge in neuroscience. J Neurochem 2009; 110(2): 457-468.
56. Toth B, Nikolajek K, Rank A, et al. Gender-specific and menstrual cycle dependent differences in circulating microparticles. Platelets 2007; 18(7): 515-521.
57. Helson R, Olszewska W, Singh M, et al. Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination. Vaccine 2008; 26(6): 753-761.
58. Marazuela EG, Prado N, Moro E, et al. Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization. Clin Exp Allergy 2008; 38(3): 520-528.
59. Lavelle EC. Lectins and microparticles for enhanced oral vaccination. Methods 2006; 38(2): 84-89.
60. Savarino A, Pescarmona GP, Boelaert JR. Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences? Cell Biochem Funct 1999; 17: 279-287.
61. Hayasaka K, Moriyama T, Chiba H, Matsuno K. Advancement of platelet activation measurement: focusing on platelet-derived microparticle measurement. Rinsho Byori 2006; 54(3): 250-255.
62. Ullal AJ, Pisetsky DS, Reich CF III. Use of SYTO 13, a fluorescent dye binding nucleic acids, for the detection of microparticles in in vitro systems. Cytometry A 2010; 77(3): 294-301.